Axcelis Technologies (NASDAQ:ACLS - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report issued on Saturday, Wall Street Zen reports.
ACLS has been the subject of a number of other research reports. Craig Hallum raised Axcelis Technologies from a "hold" rating to a "buy" rating and set a $140.00 price target for the company in a research report on Friday, November 6th. Zacks Research upgraded Axcelis Technologies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. B. Riley Financial reaffirmed a "buy" rating and set a $140.00 target price (down from $165.00) on shares of Axcelis Technologies in a report on Friday, November 6th. Finally, Weiss Ratings upgraded Axcelis Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, October 16th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $145.33.
Read Our Latest Research Report on ACLS
Axcelis Technologies Price Performance
ACLS opened at $90.36 on Friday. The stock has a market capitalization of $2.79 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 1.25 and a beta of 1.88. The stock's 50 day moving average price is $113.37 and its 200-day moving average price is $123.32. Axcelis Technologies has a 52-week low of $73.60 and a 52-week high of $193.78. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.91 and a current ratio of 4.43.
Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The semiconductor company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.15. The firm had revenue of $237.78 million for the quarter, compared to analysts' expectations of $230.08 million. Axcelis Technologies had a net margin of 11.74% and a return on equity of 11.51%. The business's revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.21 earnings per share. Axcelis Technologies has set its Q4 2026 guidance at 1.500-1.500 EPS. On average, equities research analysts predict that Axcelis Technologies will post 3.82 EPS for the current year.
Institutional Trading of Axcelis Technologies
Hedge funds have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company increased its holdings in Axcelis Technologies by 3,402.5% in the first quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company's stock valued at $45,772,000 after buying an additional 477,705 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Axcelis Technologies during the 2nd quarter valued at about $38,830,000. Barrow Hanley Mewhinney & Strauss LLC grew its position in shares of Axcelis Technologies by 40.1% during the 3rd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 549,686 shares of the semiconductor company's stock valued at $72,108,000 after acquiring an additional 157,446 shares during the period. Reinhart Partners LLC. increased its stake in shares of Axcelis Technologies by 14.2% in the 3rd quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company's stock valued at $139,134,000 after purchasing an additional 131,976 shares in the last quarter. Finally, American Century Companies Inc. raised its holdings in Axcelis Technologies by 28.3% in the 3rd quarter. American Century Companies Inc. now owns 474,455 shares of the semiconductor company's stock worth $62,239,000 after purchasing an additional 104,576 shares during the period. 89.98% of the stock is owned by hedge funds and other institutional investors.
Axcelis Technologies Company Profile
(
Get Free Report)
Axcelis Technologies develops and manufactures ion implantation equipment used in semiconductor production. Its systems introduce precisely controlled impurities into silicon wafers, helping manufacturers create the electrical properties needed for semiconductor devices. The company's product lineup includes its Purion family of ion implantation systems. Alongside equipment, Axcelis provides related services such as maintenance, upgrades, spare parts and technical support. Its products and services support semiconductor manufacturing for applications including power devices, which are used in areas such as electric vehicles and energy systems.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.